Quantum BioPharma is trading 17% up in pre-market at $3.32 as traders extend this week’s rebound from recent weakness.
- The move appears tied to a broader tech-led risk-on rally and follow-through after the July 30 gain of 5.3%.
- There is no new company-specific news or filings; the price action is driven by improving market sentiment.